BACKGROUND: The CaPTHUS model was reported to have a positive predictive value of 100 % to correctly predict single-gland disease in patients with primary hyperparathyroidism, thus obviating the need for intraoperative parathyroid hormone (ioPTH) testing. We sought to apply the CaPTHUS scoring model in our patient population and assess its utility in predicting long-term biochemical cure. METHODS: We retrospective reviewed all parathyroidectomies for primary hyperparathyroidism performed at our university hospital from 2003 to 2012. We routinely perform ioPTH testing. Biochemical cure was defined as a normal calcium level at 6 months. RESULTS: A total of 1,421 patients met the inclusion criteria: 78 % of patients had a single adenoma at the time of surgery, 98 % had a normal serum calcium at 1 week postoperatively, and 96 % had a normal serum calcium level 6 months postoperatively. Using the CaPTHUS scoring model, 307 patients (22.5 %) had a score of ≥ 3, with a positive predictive value of 91 % for single adenoma. A CaPTHUS score of ≥ 3 had a positive predictive value of 98 % for biochemical cure at 1 week as well as at 6 months. CONCLUSIONS: In our population, where ioPTH testing is used routinely to guide use of bilateral exploration, patients with a preoperative CaPTHUS score of ≥ 3 had good long-term biochemical cure rates. However, the model only predicted adenoma in 91 % of cases. If minimally invasive parathyroidectomy without ioPTH testing had been done for these patients, the cure rate would have dropped from 98 % to an unacceptable 89 %. Even in these patients with high CaPTHUS scores, multigland disease is present in almost 10 %, and ioPTH testing is necessary.
BACKGROUND: The CaPTHUS model was reported to have a positive predictive value of 100 % to correctly predict single-gland disease in patients with primary hyperparathyroidism, thus obviating the need for intraoperative parathyroid hormone (ioPTH) testing. We sought to apply the CaPTHUS scoring model in our patient population and assess its utility in predicting long-term biochemical cure. METHODS: We retrospective reviewed all parathyroidectomies for primary hyperparathyroidism performed at our university hospital from 2003 to 2012. We routinely perform ioPTH testing. Biochemical cure was defined as a normal calcium level at 6 months. RESULTS: A total of 1,421 patients met the inclusion criteria: 78 % of patients had a single adenoma at the time of surgery, 98 % had a normal serum calcium at 1 week postoperatively, and 96 % had a normal serum calcium level 6 months postoperatively. Using the CaPTHUS scoring model, 307 patients (22.5 %) had a score of ≥ 3, with a positive predictive value of 91 % for single adenoma. A CaPTHUS score of ≥ 3 had a positive predictive value of 98 % for biochemical cure at 1 week as well as at 6 months. CONCLUSIONS: In our population, where ioPTH testing is used routinely to guide use of bilateral exploration, patients with a preoperative CaPTHUS score of ≥ 3 had good long-term biochemical cure rates. However, the model only predicted adenoma in 91 % of cases. If minimally invasive parathyroidectomy without ioPTH testing had been done for these patients, the cure rate would have dropped from 98 % to an unacceptable 89 %. Even in these patients with high CaPTHUS scores, multigland disease is present in almost 10 %, and ioPTH testing is necessary.
Authors: Alejandra Gil-Cárdenas; Rosa Gamino; Alfredo Reza; Juan Pablo Pantoja; Miguel F Herrera Journal: J Am Coll Surg Date: 2006-12-18 Impact factor: 6.113
Authors: Robert Udelsman; Janice L Pasieka; Cord Sturgeon; J E M Young; Orlo H Clark Journal: J Clin Endocrinol Metab Date: 2009-02 Impact factor: 5.958
Authors: Michael W Yeh; Philip H G Ituarte; Hui Cynthia Zhou; Stacie Nishimoto; In-Lu Amy Liu; Avital Harari; Philip I Haigh; Annette L Adams Journal: J Clin Endocrinol Metab Date: 2013-02-15 Impact factor: 5.958
Authors: Nicholas Smith; Jeffrey Scott Magnuson; David Macy Vidrine; Brian Kulbersh; Glenn E Peters Journal: Arch Otolaryngol Head Neck Surg Date: 2009-11
Authors: Mitchell E Tublin; Daniel A Pryma; John H Yim; Jennifer B Ogilvie; James M Mountz; Badreddine Bencherif; Sally E Carty Journal: J Ultrasound Med Date: 2009-02 Impact factor: 2.153
Authors: M Mogollón-González; P Notario-Fernández; M Dominguez-Bastante; A Molina-Raya; M Serradilla-Martín; N Muñoz-Pérez; J I Arcelus-Martínez; J Villar-Del-Moral; J A Jiménez-Ríos Journal: Langenbecks Arch Surg Date: 2016-04-14 Impact factor: 3.445
Authors: Olov Norlén; Anthony Glover; Nisar Zaidi; Adam Aniss; Mark Sywak; Stan Sidhu; Leigh Delbridge Journal: World J Surg Date: 2015-08 Impact factor: 3.352
Authors: Mario Serradilla-Martín; Ana Palomares-Cano; Miguel Cantalejo-Díaz; Mónica Mogollón-González; Esther Brea-Gómez; Nuria Victoria Muñoz-Pérez; Juan Ignacio Arcelus-Martínez; Jesús María Villar-Del-Moral Journal: Gland Surg Date: 2021-03
Authors: Loredana De Pasquale; Eleonora Lori; Antonio Mario Bulfamante; Giovanni Felisati; Luca Castellani; Alberto Maria Saibene Journal: Int J Endocrinol Date: 2021-10-11 Impact factor: 3.257